Making Hope a Reality Through:
Research must address the mechanistic understanding, diagnosis and/or treatment of metastatic breast cancer (MBC). Preference will be for research leading directly or conceptually to translational outcomes.
Individuals with a clinical or other doctoral degree, who are actively engaged in areas of MBC research and treatment and are lawfully residing in the U.S. may apply.
Metavivor Research & Support Program. Copyright 2009 © All Rights Reserved.
METAvivor is a 501 (c)(3) non-profit volunteer organization
The METAvivor Research Program was established in 2009 with the singular goal of funding research to end death from metastatic breast cancer (MBC).
Metastatic breast cancer (MBC) occurs when breast cancer spreads to distant parts of the body such as the lung, liver, bones and brain. Each year, 41,000 Americans die of the disease.
Of the more than 200,000 Americans diagnosed annually with breast cancer, 30% will metastasize. This can occur immediately or more than 30 years later. Another 6% to 10% are metastatic when first diagnosed.
Metastasis is widespread and deadly, yet only an estimated 2% of cancer research funds go toward metastasis research.
The METAvivor Research Program intends to change this statistic by
- Awarding research grants for projects with the potential to move us closer to transitioning the now fatal disease to a permanently survivable condition with a decent quality of life
- Enhancing understanding of the disease through increased communication between the cancer researchers, oncologists and MBC patients
METAvivor’s research grants are funded through donations and proceeds from fundraisers.
METAvivor is the only US non-profit awarding research grants solely for metastatic breast cancer. The organization is run entirely by volunteers, the majority of whom have the disease.
METAvivor Research Program Overview
METAvivor Research Grant for 2013
Letter of intent due May 1st, 2013 Application due June 1st, 2013
*** 2013 Grant Opportunity ***
METAvivor research grants may be funded for one (1) year with potential extension for an additional year. Each award given will be up to the amount of $40,000/year. The research should specifically address the mechanistic understanding, diagnosis and/ or treatment, of metastatic breast cancer. Click here to download the PDF announcement for details on submission instructions and deadlines. Thank you for your interest and participation.